Home > PS Ratio > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
PS (Price/Sales) Ratio

The Current P/S Ratio of TORRENT PHARMACEUTICALS is 10.70.

Share Price ₹4,418.7Jun 05,2026
Market Cap ₹149,528.8 Cr
Sales-TTM₹13,980.0 CrTTM-Consolidated Results
Price/Sales10.70xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals

Definition & Calculation of PS (Price/Sales) ratio of TORRENT PHARMACEUTICALS

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of TORRENT PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹149,528.8 Cr] as on Jun 05,2026

(/) Sales [ ₹13,980.0 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 10.70x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for TORRENT PHARMACEUTICALS , the investors are currently willing to pay '10.70 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of TORRENT PHARMACEUTICALS !

The chart below summarizes the trend in P/S Ratio of TORRENT PHARMACEUTICALS over the last five years.

Historical PS (Price/Sales) ratio chart of TORRENT PHARMACEUTICALS


PS Ratio Performance Analysis for TORRENT PHARMACEUTICALS

- TORRENT PHARMACEUTICALS 's latest p/e ratio is 10.70x.

- TORRENT PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 7.78x.

- TORRENT PHARMACEUTICALS 's operated at median p/e ratio of 8.21x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, TORRENT PHARMACEUTICALS 's p/e ratio peaked in Mar2026 at 10.22x.

- TORRENT PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2023 of 5.41x.


How does TORRENT PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
TORRENT PHARMACEUTICALS 13,980.010.70149,528.8
SUN PHARMACEUTICAL INDUSTRIES LTD58,462.07.32427,933.0
DIVIS LABORATORIES LTD10,560.016.65175,833.0
CIPLA LTD28,162.64.02113,155.0
DR REDDYS LABORATORIES LTD33,700.23.16106,652.0
MANKIND PHARMA LTD14,277.66.7696,492.8
LUPIN LTD27,958.03.71103,705.0
ZYDUS LIFESCIENCES LTD27,148.44.04109,569.0
AUROBINDO PHARMA LTD33,653.12.5084,151.9
LAURUS LABS LTD6,812.911.4778,174.1
BIOCON LTD16,927.03.9566,789.5

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs TORRENT PHARMACEUTICALS 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.50x
Max industry PS 16.65x
Median industry PS 4.04x
Average industry PS 6.75x



You may also like the below Video Courses